Percutaneous Closure of Post-Myocardial Infarction Ventricular Septal Defect: Patient Selection and Management

Mark S Turner1, Mark Hamilton2, Gareth J Morgan1

  • 1Brisstol Heart Institute, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, United Kingdom.

Insights

Percutaneous transcatheter device closure is a viable option for treating post-myocardial infarction ventricular septal defects, offering an alternative to traditional surgery. This minimally invasive approach is discussed regarding patient selection, imaging, and procedural techniques.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Ventricular septal defects (VSDs) can occur as a complication following myocardial infarction (heart attack).
  • Traditional treatment involves open-heart surgery with patch repair, which carries significant risks.
  • Minimally invasive techniques are being explored to improve patient outcomes.

Purpose of the Study:

  • To evaluate the feasibility of percutaneous transcatheter device closure for post-myocardial infarction VSD.
  • To compare this approach with conventional surgical patch repair.
  • To discuss key aspects of the interventional procedure.

Main Methods:

  • Review of percutaneous transcatheter device closure techniques for VSD.
  • Discussion of patient selection criteria and pre-procedural imaging modalities.
  • Analysis of procedural timing, technical considerations, and outcomes.

Main Results:

  • Percutaneous transcatheter device closure is demonstrated as a feasible alternative to surgical repair.
  • Successful closure of post-myocardial infarction VSDs using device closure is achievable.
  • The approach offers potential benefits in terms of reduced invasiveness.

Conclusions:

  • Transcatheter device closure represents a promising, less invasive option for managing post-myocardial infarction VSDs.
  • Careful patient selection, appropriate imaging, and precise technique are crucial for successful outcomes.
  • Further research may solidify its role as a standard treatment modality.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
400
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
376
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
438
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
450
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347